Additionally, ISG15 is associated with tumor angiogenesis, as its inhibition in certain cancers reduces the secretion of angiogenesis-related factors such as VEGF and IL-6, leading to suppressed tumor growth and invasiveness [12]. Here, VEGFA is linked to neoplasm.